Gastric adenocarcinoma of the fundic gland type shares common genetic and phenotypic features with pyloric gland adenoma

Pathology International

Volumn 63, Issue 6, 2013, Pages 318-325

  Kushima, Ryoji ^a   Sekine, Shigeki ^b   Matsubara, Akiko ^a   Taniguchi, Hirokazu ^a   Ikegami, Masahiro ^c   Tsuda, Hitoshi ^a,d  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Chief cell; Gastric adenocarcinoma of the fundic gland type; GNAS; Mucous neck cell; Pyloric gland adenoma

Indexed keywords

HYDROGEN POTASSIUM ADENOSINE TRIPHOSPHATASE; MUCIN 6; PEPSINOGEN I;

ADULT; AGED; ARTICLE; CANCER PATIENT; CELL DIFFERENTIATION; CLINICAL ARTICLE; COMPARATIVE STUDY; FEMALE; GASTRIC ADENOCARCINOMA OF THE FUNDIC GLAND; GENE MUTATION; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYLORIC GLAND ADENOMA; STOMACH ADENOCARCINOMA; STOMACH CHIEF CELL; STOMACH PARIETAL CELL; ADENOCARCINOMA; ADENOMA; GENETICS; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PATHOLOGY; STOMACH MUCOSA; STOMACH TUMOR;

ADENOCARCINOMA; ADENOMA; AGED; CHIEF CELLS, GASTRIC; DNA MUTATIONAL ANALYSIS; FEMALE; GASTRIC MUCOSA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PHENOTYPE; STOMACH NEOPLASMS;

EID: 84879439653     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/pin.12070     Document Type: Article

References (16)

1. Ueyama H, Yao T, Nakashima Y etal. Gastric adenocarcinoma of fundic gland type (chief cell predominant type): Proposal for a new entity of gastric adenocarcinoma. Am J Surg Pathol 2010; 34: 609-619.
2. Singhi AD, Lazenby AJ, Montgomery EA. Gastric adenocarcinoma with chief cell differentiation: A proposal for reclassification as oxyntic gland polyp/adenoma. Am J Surg Pathol 2012; 36: 1030-1035.
3. Chen ZM, Scudiere JR, Abraham SC, Montgomery E. Pyloric gland adenoma: An entity distinct from gastric foveolar type adenoma. Am J Surg Pathol 2009; 33: 186-193.
4. Kushima R, Vieth M, Borchard F, Stolte M, Mukaisho K, Hattori T. Gastric-type well-differentiated adenocarcinoma and pyloric gland adenoma of the stomach. Gastric Cancer 2006; 9: 177-184.
5. Vieth M, Kushima R, Borchard F, Stolte M. Pyloric gland adenoma: A clinico-pathological analysis of 90 cases. Virchows Arch 2003; 442: 317-321.
6. Matsubara A, Sekine S, Kushima R etal. Frequent GNAS and KRAS mutations in pyloric gland adenoma of the stomach and duodenum. J Pathol 2013; 229: 579-587.
7. Montgomery EA, Voltaggio L. Biopsy Interpretation of the Gastrointestinal Tract Mucosa. Volume 2: Neoplastic. Philadelphia, PA: Wolters Kluwer/Lippincott Williams & Wilkins, 2012; 85-88.
8. Lennerz JK, Kim SH, Oates EL etal. The transcription factor MIST1 is a novel human gastric chief cell marker whose expression is lost in metaplasia, dysplasia, and carcinoma. Am J Pathol 2010; 177: 1514-1533.
9. Hattori T, Fujita S. Tritiated thymidine autoradiographic study on cellular migration in the gastric gland of the golden hamster. Cell Tissue Res 1976; 172: 171-184.
10. Hanby AM, Poulsom R, Playford RJ, Wright NA. The mucous neck cell in the human gastric corpus: A distinctive, functional cell lineage. J Pathol 1999; 187: 331-337.
11. Cornaggia M, Capella C, Riva C, Finzi G, Solcia E. Electron immunocytochemical localization of pepsinogen I (PgI) in chief cells, mucous neck cells and transitional mucous-neck/chief cells of the human fundic mucosa. Histochemistry 1986; 85: 5-11.
12. Bredemeyer AJ, Geahlen JH, Weis VG etal. The gastric epithelial progenitor cell niche and differentiation of the zymogenic (chief) cell lineage. Dev Biol 2009; 325: 211-224.
13. Ramsey VG, Doherty JM, Chen CC, Stappenbeck TS, Konieczny SF, Mills JC. The maturation of mucus-secreting gastric epithelial progenitors into digestive-enzyme secreting zymogenic cells requires Mist1. Development 2007; 134: 211-222.
14. Landis CA, Masters SB, Spada A, Pace AM, Bourne HR, Vallar L. GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature 1989; 340: 692-696.
15. Freda PU, Chung WK, Matsuoka N etal. Analysis of GNAS mutations in 60 growth hormone secreting pituitary tumors: Correlation with clinical and pathological characteristics and surgical outcome based on highly sensitive GH a nd IGF-I criteria for remission. Pituitary 2007; 10: 275-282.
16. Lee SH, Jeong EG, Soung YH, Lee JW, Yoo NJ, Lee SH. Absence of GNAS and EGFL6 mutations in common human cancers. Pathology 2008; 40: 95-97.